MIR4435-2HG and chronic recurrent multifocal osteomyelitis: We also conjecture that Morrbid could be a target for potential anti-sense oligonucleotide (ASO) drugs, and the progression of CRMO can be blocked or alleviated by anti-Morrbid ASO drugs.